<DOC>
	<DOC>NCT01006564</DOC>
	<brief_summary>To determine if functional MRI methods will aid planning of a radiation dose boost within the prostate in patients with prostate cancer potentially improving safety and efficacy.</brief_summary>
	<brief_title>Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Hormone therapy naive patients planned to be treated by radical radiotherapy after 36 months of androgen suppression Patients with lowhigh risk histologically confirmed localised disease are eligible, with WHO performance status 01. Patients unsuitable for functional MRI of the prostate or gold seed fiducial marker insertion (e.g. patients unable to tolerate endorectal MRI examination). No prior pelvic radiotherapy or radical prostatectomy, previous androgen therapy, patients unsuitable for radical radiotherapy, life expectancy &lt;10 years, previous active malignancy within last 5 years, comorbid conditions likely to impact on the advisability of radical radiotherapy, full anticoagulation, other exclusions to MRI (e.g. hip prosthesis or fixation, claustrophobia, ferromagnetic implants).</criteria>
	<gender>Male</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Prostate Cancer</keyword>
	<keyword>Magnetic Resonance Spectroscopy</keyword>
	<keyword>Radiotherapy planning</keyword>
</DOC>